+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Computational and Experimental Design of Biopharmaceutical Formulations

  • Book

  • November 2021
  • Elsevier Science and Technology
  • ID: 5342218
Computational and Experimental Design of Biopharmaceutical Formulations outlines available experimental and computational tools. It describes a rational approach to formulation design not limited by experimental design that  extends to modern methods of computational modeling. These methods include the modeling of protein structure and dynamics, and of solution properties in the presence of proteins and excipients. The chapters in this book consider computational modeling of protein-solution interactions, the design of early-stage formulation studies, the design of late-stage formulation studies, automation, high-throughput and control, design of lyophilized formulations, and emerging technologies in the future formulation development.

Table of Contents

1. Introduction 2. Computational modeling of protein-solution interactions 3. Design of early stage formulation studies 4. Design of late stage formulation studies 5. Automation, high throughput and control 6. Design of lyophilized formulations 7. Emerging technologies and formulation development of the future

Authors

Vladimir I. Razinkov Department of Drug Product Development, Amgen Inc., Seattle, WA, USA. Vladimir Razinkov is a principal scientist in the Department of Drug Product Development, Amgen Inc., Seattle, WA, USA Arnold McAuley Department of Drug Product Development, Amgen, Thousand Oaks, CA, USA. Arnold McAuley works in the Department of Drug Product Development at Amgen, Thousand Oaks, CA, USA. Pavan Ghattyvenkatakrishna Department of Drug Product Development, Amgen, Thousand Oaks, CA, USA. Pavan Ghattyvenkatakrishna works in the Department of Drug Product Development in Amgen, Thousand Oaks, CA, USA Deirdre Piedmonte Department of Drug Product Development, Amgen, Thousand Oaks, CA, USA. Deirdre Piedmonte works in the Department of Drug Product Development at Amgen, Thousand Oaks, CA, USA.